ReCerf Receives CE Mark, Enhancing Access to Ceramic Hip Resurfacing Throughout Europe

ReCerf: A New Era in Hip Resurfacing Surgery

In a groundbreaking achievement for orthopedic innovation, MatOrtho® has announced that its ReCerf® Hip Resurfacing Arthroplasty (HRA) has received the prestigious CE mark. This certification signifies compliance with Europe's rigorous safety and performance standards, marking a significant step forward in enhancing access to hip prosthetics throughout the continent, specifically in the UK and broader European markets.

Mike Tuke, the founder of MatOrtho, elaborated on the importance of this milestone, stating, "This is more than just a regulatory achievement; it represents two decades of dedicated efforts aimed at enhancing hip arthroplasty through advanced materials." The ReCerf HRA showcases the innovative use of BIOLOX® delta ceramic, developed in collaboration with CeramTec A.G. This result is a fully ceramic resurfacing implant that has already demonstrated excellent patient outcomes.

Initially approved in November 2024 by the Australian Therapeutic Goods Administration, the ReCerf has since transformed the lives of over 1,600 patients since its first deployment in 2018. Feedback from these patients has been overwhelmingly positive, with notably low revision rates documented even up to six years post-operation.

One of the key advantages of the ReCerf HRA is its composition. Unlike traditional metal-on-metal bearing surfaces, this ceramic implant alleviates the problems associated with metal wear, while preserving more of the patient's natural bone structure. For surgeons, it presents a familiar procedure enhanced by the benefits of superior materials, underpinned by a company renowned for its commitment to modern hip resurfacing technologies.

MatOrtho underscores its dedication to responsible adoption practices alongside the availability of the ReCerf under CE certification. As part of this commitment, the company is implementing structured training programs for surgeons and ensuring meticulous patient selection and ongoing clinical monitoring. There is already a peer-led training initiative in place, designed to guarantee the safe and effective application of this pioneering procedure.

This major accomplishment not only underlines MatOrtho's strategic growth objectives but solidifies its leadership role in providing groundbreaking orthopedic solutions aimed at restoring normal joint function and supporting high levels of activity among patients. The rollout of ReCerf across Europe signals a new chapter in orthopedic surgery, offering enhanced possibilities for those requiring hip resurfacing.

For additional information about the ReCerf product, please visit ReCerf.com. MatOrtho, formerly known as Finsbury Orthopaedics, continues to lead the way in orthopedic advancements, dedicated to improving patient outcomes and setting new clinical standards in joint replacement technology. To learn more about MatOrtho, visit their official website at matortho.com/recerf.